ES8502865A1 - Procedimiento para producir una composicion farmaceutica nasal mejorada. - Google Patents
Procedimiento para producir una composicion farmaceutica nasal mejorada.Info
- Publication number
- ES8502865A1 ES8502865A1 ES519450A ES519450A ES8502865A1 ES 8502865 A1 ES8502865 A1 ES 8502865A1 ES 519450 A ES519450 A ES 519450A ES 519450 A ES519450 A ES 519450A ES 8502865 A1 ES8502865 A1 ES 8502865A1
- Authority
- ES
- Spain
- Prior art keywords
- medicinal composition
- carbon dioxide
- agent capable
- ciliary function
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 2
- 239000001569 carbon dioxide Substances 0.000 abstract 2
- 230000001886 ciliary effect Effects 0.000 abstract 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 abstract 1
- 229960004704 dihydroergotamine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8202781 | 1982-02-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES519450A0 ES519450A0 (es) | 1985-02-01 |
| ES8502865A1 true ES8502865A1 (es) | 1985-02-01 |
Family
ID=10528017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES519450A Expired ES8502865A1 (es) | 1982-02-01 | 1983-02-01 | Procedimiento para producir una composicion farmaceutica nasal mejorada. |
Country Status (27)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
| GB0910375D0 (en) * | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
| ES2937440T3 (es) * | 2018-01-05 | 2023-03-28 | Impel Pharmaceuticals Inc | Administración intranasal de dihidroergotamina mediante un dispositivo olfativo de precisión |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3091569A (en) * | 1960-08-26 | 1963-05-28 | Mead Johnson & Co | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus |
| GB1202885A (en) * | 1966-12-22 | 1970-08-19 | Sandoz Ltd | Pharmaceutical compositions comprising alkaloids |
| DE2750090A1 (de) * | 1976-11-19 | 1978-06-01 | Sandoz Ag | Neue verabreichungsformen fuer organische verbindungen |
| FR2387035A1 (fr) * | 1977-04-12 | 1978-11-10 | Cassenne Lab Sa | Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux |
| DE2831728C2 (de) * | 1978-07-19 | 1982-12-23 | Krewel-Werke Gmbh, 5208 Eitorf | Arzneimittel zur Behandlung von Kopfschmerzen |
-
1983
- 1983-01-25 FI FI830245A patent/FI81258C/fi not_active IP Right Cessation
- 1983-01-27 FR FR8301228A patent/FR2539994B1/fr not_active Expired
- 1983-01-28 NZ NZ203117A patent/NZ203117A/en unknown
- 1983-01-28 CH CH495/83A patent/CH653555A5/de not_active IP Right Cessation
- 1983-01-28 NL NL8300325A patent/NL192325C/nl not_active IP Right Cessation
- 1983-01-28 PH PH28445A patent/PH22198A/en unknown
- 1983-01-28 AU AU10850/83A patent/AU565613B2/en not_active Expired
- 1983-01-29 DE DE19833302949 patent/DE3302949A1/de active Granted
- 1983-01-31 LU LU84613A patent/LU84613A1/fr unknown
- 1983-01-31 HU HU83323A patent/HU191512B/hu unknown
- 1983-01-31 IE IE187/83A patent/IE54532B1/en not_active IP Right Cessation
- 1983-01-31 BE BE1/10708A patent/BE895750A/fr not_active IP Right Cessation
- 1983-01-31 AT AT0030383A patent/AT385656B/de not_active IP Right Cessation
- 1983-01-31 DK DK038183A patent/DK164771C/da not_active IP Right Cessation
- 1983-01-31 SE SE8300495A patent/SE454402B/sv not_active IP Right Cessation
- 1983-01-31 CA CA000420539A patent/CA1197783A/en not_active Expired
- 1983-01-31 GR GR70362A patent/GR81320B/el unknown
- 1983-01-31 PT PT76166A patent/PT76166B/pt unknown
- 1983-01-31 JP JP58015392A patent/JPS58134017A/ja active Granted
- 1983-02-01 IT IT47646/83A patent/IT1197558B/it active
- 1983-02-01 ZA ZA83673A patent/ZA83673B/xx unknown
- 1983-02-01 IL IL67822A patent/IL67822A/xx not_active IP Right Cessation
- 1983-02-01 ES ES519450A patent/ES8502865A1/es not_active Expired
-
1987
- 1987-12-30 MY MY766/87A patent/MY8700766A/xx unknown
-
1989
- 1989-05-25 SG SG343/89A patent/SG34389G/en unknown
- 1989-06-21 KE KE3888A patent/KE3888A/xx unknown
- 1989-07-27 HK HK599/89A patent/HK59989A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1525448A (en) | Dialysis membrane for haemodialysis | |
| DE3686764D1 (de) | Medizinischer fluessigkeitsbehaelter und dessen herstellung. | |
| BR9809177A (pt) | Comprimidos, e processo para fabricação de comprimidos | |
| NO802843L (no) | Fremgangsmaate for fremstilling av aktivt karbon i fibroes form | |
| ES8201419A1 (es) | Un metodo para preparar una solucion acuosa de nitrogliceri-na | |
| PH12784A (en) | 5-droxy-5-fluorocytidine,5-deoxy-5-fluorouridine and pharmaceutically acceptable acid addition salts thereof | |
| IT8020245A0 (it) | Procedimento e dispositivo perl'azionamento di un corpo rigido in modo da ottenere pure il movimento oscillante durante il movimento di rotazione del corpo stesso. | |
| EA200200151A1 (ru) | Сухая порошкообразная композиция | |
| ES8502865A1 (es) | Procedimiento para producir una composicion farmaceutica nasal mejorada. | |
| ZA80647B (en) | Active electrode,electrochemical cell comprising the electrode and method of forming electrode | |
| FI911207A0 (fi) | Menetelmä uuden terapeuttisesti käyttökelpoisen retinoidin valmistamiseksi | |
| JPS5359018A (en) | Concentrated xiii-th blood coagulating factor derived from human placentaand its preparation | |
| FR2356642B1 (fr) | La 2-bromo-6-fluoro-n-2-imidazolinylidene-benzamine, ses sels d'addition avec des acides, procedes pour leur preparation et les medicaments les renfermant | |
| IE38028L (en) | Compositions having a physiological cooling effect | |
| ZA772514B (en) | Improvements relating to the administration of pharmaceutically active substances to animals | |
| JPS52105220A (en) | Composition for rectal administration comprising beta-lactam ring containing substance and method of making same | |
| DE3586457D1 (de) | Solubilisierungsverfahren im moment der anwendung eines aktiven lipophilen prinzipes in waessriger loesung zum zweck der intravenoesen verabreichung. | |
| SE8101963L (sv) | Monohydrerad isoftalsyrapikolylamid, forfarande for dess framstellning samt farmaceutisk anvendning derav | |
| CA989834A (en) | 3,4-dihydro-6,7-substituted-2,3-lower alkyl-4-oxo-1(2h)-quinazolecarboxylic acid derivatives useful as analgesic and tranquilizer agents | |
| IE831551L (en) | Eye ointment. | |
| JPS57144214A (en) | Pharmaceutical preparation for rectum medication | |
| HU177758B (en) | Selective herbicide composition containing diurethane as active agent,and process for producing the active agent | |
| USD221365S (en) | Medical diagnostic console | |
| JPS52148615A (en) | Aqueous biologically active solution | |
| ZA77200B (en) | Herbicidally active 5-alkylureido-1,3,4-thiadiazol-2-yl-sulphonyl-acetic acid derivatives,process for their manufacture and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1A | Transfer granted |